Status:
COMPLETED
Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism
Lead Sponsor:
Bayer
Conditions:
Hypogonadism
Eligibility:
MALE
18-75 years
Phase:
PHASE3
Brief Summary
This study will evaluate the preparation of testosterone undecanoate under conditions which resemble real-life situations.
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Eligibility Criteria
Inclusion
- Hypogonadal men, aged 18-75 years with low serum total testosterone (TT) levels and symptoms of androgen deficiency
Exclusion
- Tumors of the prostate or the male mammary gland including suspicion thereof. Past or present liver tumors or chronic hepatic disease with impairment of liver function, Severe acne.
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT00220298
Start Date
February 1 2003
End Date
October 1 2007
Last Update
December 30 2014
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Nuremberg, Bavaria, Germany, 90441
2
Marburg, Hesse, Germany, 35037
3
Wolfsburg, Lower Saxony, Germany, 38440
4
Münster, North Rhine-Westphalia, Germany, 48129